HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Raises Price Target to $26
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Robert Burns maintains a Buy rating on Repare Therapeutics (NASDAQ:RPTX) and raises the price target from $25 to $26.
June 09, 2023 | 10:26 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Repare Therapeutics (NASDAQ:RPTX) receives a maintained Buy rating and an increased price target of $26 from HC Wainwright & Co.
The maintained Buy rating and increased price target from HC Wainwright & Co. indicate a positive outlook for Repare Therapeutics. This news is likely to have a positive impact on the stock price in the short term as it reflects the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100